Aim: This study's goal is to identify the prevalence of H. pylori infection among patients with recurrent gastric ulcers in Arbil, Iraq. Study design: A cross-sectional study Place & duration of the study: From Oct 2021 to Feb 2022 in the private laboratories in Arbil city/Iraq. Methodology: A total of 83 patients with recurrent gastric ulcers were admitted to the private laboratories in Arbil city. Blood samples were collected for detection of anti-Helicobacter pylori antibodies IgG and IgA in patient serum samples by the serological method by Enzyme-linked immunosorbent assays. A special questionnaire sheet was designed and used for each patient subject. Results: Among 83 screened samples, the overall seroprevalence rate of H. pylori infection patients with recurrent gastric ulcer was 47 (56.6%). H. pylori infection was more common in female patients (59.1%) compared to male patients (53.8%). The rate of Helicobacter pylori infection was higher (84.2%) among the young adult-aged patient group (21-30) years, and (63.4%) in urban patients. A higher seropositive rate of H. pylori infection was among married patients (51.8%). Regarding marital status, most of the seropositive patients were among married patients (51.8%), (64%) among nonuse therapy, (56.7%) in the A blood group, (66.6%) among severe symptom patients, and (69.2%) among patients with a previous history of H. pylori infection respectively. Conclusions: Patients with recurrent stomach ulcers had greater levels of helicobacter pylori antibodies, which were linked to negative outcomes. Keywords: H. pylori, gastric ulcer, recurrent infection IgG, IgA
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.